IS TREATMENT-RESISTANCE IN PSYCHIATRIC DISORDERS A TRAP FOR POLYPHARMACY?

被引:0
|
作者
Jasovic-Gasic, Miroslava [1 ]
机构
[1] Univ Belgrade, Fac Med, Acad Med Sci, Serbian Med Soc, Belgrade 11000, Serbia
关键词
treatment resistance; polypharmacy; schizophrenia; psychiatric disorders; DOPAMINE SYNTHESIS CAPACITY; NEGATIVE SYMPTOMS; DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; ELECTROCONVULSIVE-THERAPY; CHRONIC-SCHIZOPHRENIA; CLOZAPINE TREATMENT; CLINICAL-RESPONSE; METAANALYSIS; AUGMENTATION;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Nowadays, more and more mental health professionals manage patients who fail treatment for major psychiatric disorders. There is not a consensus on how to deal with treatment-resistance patients, but usually psychiatrists result to polypharmacy. Method: In reviewing the evidence based clinical research we will try to answer some questions about treatment-resistant psychiatric disorders. Treatment-resistant symptoms complicate the clinical course of all psychiatric disorders especially schizophrenia, causing the patients not to reach the therapeutical goal and enter remission. In consequence, polypharmacy is used to try to deal with the remaining symptoms, raising other issues. Summary: We will try to deal with this problematic issue through clinical studies and major research done to try and answer the question posed.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 50 条
  • [21] Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance
    Costello, Harry
    Roiser, Jonathan P.
    Howard, Robert
    PSYCHOLOGICAL MEDICINE, 2023, 53 (03) : 654 - 667
  • [22] Antiepileptic drugs in the treatment of psychiatric disorders
    Kaufman, Kenneth R.
    EPILEPSY & BEHAVIOR, 2011, 21 (01) : 1 - 11
  • [23] Role of Ketamine in the Treatment of Psychiatric Disorders
    Derakhshanian, Sahar
    Zhou, Maxine
    Rath, Alexander
    Barlow, Rachel
    Bertrand, Sarah
    DeGraw, Caroline
    Lee, Christopher
    Hasoon, Jamal
    Kaye, Alan D.
    HEALTH PSYCHOLOGY RESEARCH, 2021, 9 (01):
  • [24] Factors associated with self-perceived treatment-resistance in bipolar disorder
    Fujimura, Toshimasa
    Taira, Daiki
    Uchida, Yoshihiro
    Takahashi, Keitaro
    Yamasuji, Kanako
    Shimizu, Kentaro
    Nagai, Yasuhito
    Yoshinari, Naoto
    Hirata, Tomoe
    Fujimoto, Kazuma
    Kurosawa, Yui
    Yasuda, Seita
    Yoshikawa, Akane
    Takeshita, Yoshihide
    Ito, Masanobu
    Kakiuchi, Chihiro
    Kato, Tadafumi
    MEDICINE, 2024, 103 (01) : E36217
  • [25] The Role of rTMS in the Treatment of Psychiatric Disorders Other than Major Depression
    Grammer, Geoffrey
    Green, Vanessa
    Amin, Rohul
    Alampay, Miguel
    PSYCHIATRIC ANNALS, 2014, 44 (06) : 293 - 298
  • [26] Advances in the treatment of psychiatric disorders in long-term care homes
    Conn, David K.
    Seitz, Dallas P.
    CURRENT OPINION IN PSYCHIATRY, 2010, 23 (06) : 516 - 521
  • [27] Electroconvulsive Therapy as Maintenance Treatment in Psychiatric Disorders
    Ilambaridhi Balasubramanian
    Bandita Abhijita
    Vikas Menon
    Current Behavioral Neuroscience Reports, 2024, 11 : 1 - 13
  • [28] Electroconvulsive Therapy as Maintenance Treatment in Psychiatric Disorders
    Balasubramanian, Ilambaridhi
    Abhijita, Bandita
    Menon, Vikas
    CURRENT BEHAVIORAL NEUROSCIENCE REPORTS, 2024, 11 (01) : 1 - 13
  • [29] Hepatitis C Treatment for Patients with Psychiatric Disorders
    Schaefer, M.
    SUCHTTHERAPIE, 2009, 10 (03) : 118 - 124
  • [30] Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics
    Rittmannsberger, H
    Meise, U
    Schauflinger, K
    Horvath, E
    Donat, H
    Hinterhuber, H
    EUROPEAN PSYCHIATRY, 1999, 14 (01) : 33 - 40